Impact of micronutrients on anxiety-depressive disorders in type 2 diabetics

##plugins.themes.academic_pro.article.main##

Olfa Berriche
Hana Ben Jemaa
Rym Ben Othman
Ramla Mizouri
Amel Gamoudi
Henda Jamoussi

Abstract

Introduction : Micronutrient deficiencies are common in type 2 diabetics (T2D), promoting the occurrence of anxiety-depressive disorders.


Aim : The objectives of this study were to evaluate the micronutrient status of patients with type 2 diabetes (T2D), screen them for anxiety-depressive disorders, and investigate associations between these disorders and micronutrient intake.


Methods : This was a descriptive cross-sectional study involving 115 type 2 diabetics. They underwent a dietary survey and completed the Hospital Anxiety and Depression Scale (HAD) and Dopamine/Norepinephrine/Serotonin (DNS) questionnaires assessing anxiety-depressive disorders.


Results : Deficiencies in the intake of vitamins (A, E, C, B) and minerals (magnesium, copper, iron, zinc) were noted. Negative and significant associations were found between depression scores and the intake of vitamin B1 (p=0.01) and vitamin B6 (p=0.024). Similarly, negative and significant associations were found between anxiety scores and the intake of vitamin B6 (p=0.049), vitamin B9 (p=0.019), and vitamin B12 (p=0.01). Referring to the DNS score, we found negative associations between the dopamine score and the intake of vitamin B9 (p=0.002), magnesium (p=0.003), and copper (p=0.007) ; between the norepinephrine score and the intake of vitamin C (p=0.046), vitamin B6 (p<0.001), magnesium (p=0.024), and zinc (p=0.009); and between the serotonin score and the intake of vitamin B12 (p=0.001), magnesium (p=0.027), and zinc (p=0.047).


Conclusion : micronutrient deficiencies can exacerbate pre-existing anxiety and depressive disorders in type 2 diabetics. Systematic nutritional education is recommended, emphasizing a balanced and varied diet rich in vitamins and minerals.

Keywords:

type 2 diabetes, micronutrients, score, anxiety-depressive disorders

##plugins.themes.academic_pro.article.details##

References

  1. Data & research on diabetes. Centers for Disease Control and Prevention. Published 2024. Available from: https://www.cdc.gov/diabetes/php/data-research/index.html. Accessed December 29, 2024.
  2. Huang CQ, Dong BR, Lu ZC, Yue JR, Liu QX. Chronic diseases and risk for depression in old age: a meta-analysis of published literature. Ageing Res Rev. 2010 Apr;9(2):131-41.
  3. Gonzalez JS, Hood KK, Esbitt SA, Mukherji S, Kane NS, & Jacobson A (2015). Psychiatric and psychosocial issues among individuals living with diabetes Diabetes in America. 2nd ed NIDDK.
  4. Li C, Barker L, Ford ES, Zhang X, Strine TW, Mokdad AH. Diabetes and anxiety in US adults: findings from the 2006 Behavioral Risk Factor Surveillance System. Diabet Med. 2008 Jul;25(7):878-81.
  5. Asman AG, Hoogendoorn CJ, McKee MD, Gonzalez JS. Assessing the association of depression and anxiety with symptom reporting among individuals with type 2 diabetes. J Behav Med. 2020 Feb;43(1):57-68.
  6. Katon W. The effect of major depression on chronic medical illness. Semin Clin Neuropsychiatry. 1998 Apr;3(2):82-86.
  7. Mora PA, Halm E, Leventhal H, Ceric F. Elucidating the relationship between negative affectivity and symptoms: the role of illness-specific affective responses. Ann Behav Med. 2007 Aug;34(1):77-86.
  8. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry. 2007 Mar-Apr;29(2):147-55.
  9. Reddy P, Philpot B, Ford D, Dunbar JA. Identification of depression in diabetes: the efficacy of PHQ-9 and HADS-D. Br J Gen Pract. 2010;60(575):e263-e270.
  10. Twist K, Stahl D, Amiel SA, Thomas S, Winkley K, Ismail K. Comparison of depressive symptoms in type 2 diabetes using a two-stage survey design. Psychosom Med. 2013 Oct;75(8):791-7.
  11. Kaur B, Henry J. Micronutrient status in type 2 diabetes: a review. Adv Food Nutr Res. 2014;71:55-100.
  12. Régime alimentaire, nutrition et prévention des maladies chroniques: rapport d’une consultation OMS/FAO d’experts ; [Consultation OMS/FAO d’Experts sur le Régime Alimentaire, la Nutrition et la Prévention des Maladies Chroniques, Genève, 28 janvier - 1. Février 2002]. 2003.
  13. Authority (EFSA) EFS. Dietary Reference Values for nutrients Summary report. EFSA Support Publ. 2017;14: e15121E.
  14. Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail. Les références nutritionnelles en vitamines et minéraux [online]. Anses. [cited 2024 Dec 26]. Available from: https://www.anses.fr/fr/content/les-r%C3%A9f%C3%A9rences-nutritionnelles-en-vitamines-et-min%C3%A9raux.
  15. Les lipides [Internet]. Anses - Agence Natl. Sécurité Sanit. L’alimentation L’environnement Trav. 2021 [cité 9 oct 2023]. Disponible sur: https://www.anses.fr/fr/content/les-lipides.
  16. Courcy G, Frelut ML, Fricker J, Dupin M. Besoins nutritionnels et apports conseillés pour la satisfaction de ces besoins. EMC – Endocrinologie-Nutrition 2003;14(1):1-32 [Article 10-308-A-10]
  17. Caron N. Estimation de la dépense énergétique chez des personnes diabétiques de type 2 à l’aide de capteurs « intelligents » [thèse : sciences technologie santé ]. La Réunion: Université de la Réunion; 2017.
  18. Authority (EFSA) EFS. Dietary Reference Values for nutrients Summary report. EFSA Support Publ. 2017;14: e15121E.
  19. Human energy requirements [Internet]. [Cité 28 sept 2023]. Disponible sur: https://www.fao.org/3/y5686e/y5686e00.htm
  20. Le questionnaire (HAD) [Internet]. IEDM [cited 2024 Dec 26]. Available from: https://www.iedm.asso.fr/le-questionnaire-had/
  21. Le DNS (Dopamine / Noradrénaline / Sérotonine) (français, anglais et espagnol) [Internet]. [cited 2024 Oct 2]. Available from: https://www.iedm.asso.fr/le-dns-dopamine-noradrenaline-serotonine-francais-anglais-et-espagnol/
  22. Mooradian AD, Morley JE. Micronutrient status in diabetes mellitus. Am J Clin Nutr. 1987;45:877-95.
  23. Nur Rosyid F. Micronutrient deficiency in type 1 and 2 diabetes mellitus: diagnosis and therapy. Int J Res Med Sci. 2022;10:973.
  24. Jacka FN, Overland S, Stewart R, Tell GS, Bjelland I, Mykletun A. Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. Aust N Z J Psychiatry. 2009 Jan;43(1):45-52.
  25. Mahjoub F, Moalla H, Ben Amor N, Souissi N, Jendoubi H, Lahmer I, et al. Profil nutritionnel des diabétiques de type 2 hospitalisés. Ann Endocrinol. 2021;82:505.
  26. Dietary intake of adults with and without diabetes: results from NHANES 2013–2016. BMJ Open Diabetes Res Care [Internet]. 2023 Nov 28 [cited 2024 Nov 28]. Available from: https://drc.bmj.com/content/8/1/e001681.abstract
  27. Hercberg S, Preziosi P, Galan P, Deheeger M, Papoz L, Dupin H. Dietary intake of a representative sample of the population of Val-de-Marne; III. Mineral and vitamin intake. Rev Epidemiol Sante Publique. 1991;39:245-61.
  28. Jagielski AC, Brown A, Hosseini-Araghi M, Thomas GN, Taheri S. The association between adiposity, mental well-being, and quality of life in extreme obesity. PLoS One. 2014 Mar 26;9(3):e92859.
  29. Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007 Feb 1;61(3):348-58.
  30. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006 Nov;23(11):1165-73.
  31. Fisher L, Skaff MM, Mullan JT, Arean P, Glasgow R, Masharani U. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with Type 2 diabetes. Diabet Med. 2008 Sep;25(9):1096-101.
  32. Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009 Feb;26(2):153-61.
  33. Stevanovic D, Popović L, Avicenna M, Petek Erić A, et al. Anxiety and depressive disorders in diabetes. In: Sadikot's International Textbook of Diabetes. 2nd ed. Chapter 126. New Delhi: Jaypee-Highlights Medical Publishers; 2024. p. 1040-1049.
  34. Bădescu SV, Tătaru C, Kobylinska L, Georgescu EL, Zahiu DM, Zăgrean AM, et al. The association between Diabetes mellitus and Depression. J Med Life. 2016 Apr-Jun;9(2):120-5.
  35. Mikawa Y, Mizobuchi S, Egi M, Morita K. Low serum concentrations of vitamin B6 and iron are related to panic attack and hyperventilation attack. Acta Med Okayama. 2013;67(2):99-104.
  36. Guilland J-C. Vitamines hydrosolubles (I). Thiamine, riboflavine, niacine, acide pantothénique, vitamine B6 et biotine. EMC-Endocrinol Nutr. 2012 Oct;9(4):1-28.
  37. Kelly G. The co-enzyme forms of vitamin B12: Toward an understanding of their therapeutic potential. Altern Med Rev. 1997;2(6):459-71.
  38. Jain A, Sharma R, Choudhary PK, Yadav N, Jain G, Maanju M. Study of fatigue, depression, and associated factors in type 2 diabetes mellitus in industrial workers. Ind Psychiatry J. 2015; 24:179‑84.
  39. Chronobiologie-de-lhumeur.pdf [Internet]. [cited 2023 Nov 4]. Available from: http://institut-biologie-nutritionnelle.fr/wp-content/uploads/2016/12/Chronobiologie-de-lhumeur.pdf
  40. Baron S. Alimentation santé et micronutrition: approche globale adaptée à l’officine chez l’adulte [thesis]. Rouen: Université de Rouen; 2014.
  41. Troubles du sommeil: le tryptophane, précurseur de la mélatonine [Internet]. [cited 2023 Dec 8]. Available from: https://nhco-nutrition.com/journal/sommeil-tryptophane-melatonine/
  42. Tarasov EA, Blinov DV, Zimovina UV, Sandakova EA. Magnesium deficiency and stress: Issues of their relationship, diagnostic tests, and approaches to therapy. Ter Arkh. 2015;87(9):114-122.
  43. Colin S. Place de la micronutrition dans la prise en charge de l’anxiété et des troubles du sommeil, y compris les compléments alimentaires [thesis]. Rennes: Université de Bretagne Loire; 2016.